Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.33B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$985M |
| 3 |
Eli Lilly
LLY
|
+$901M |
| 4 |
Toronto Dominion Bank
TD
|
+$796M |
| 5 |
Blackrock
BLK
|
+$544M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$857M |
| 2 |
NVIDIA
NVDA
|
+$803M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$676M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$671M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 15.76% |
| 3 | Industrials | 7.12% |
| 4 | Healthcare | 6.97% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Alkami Technology
ALKT
$2.22B
| $20.8M | ﹤0.01% |
792,182
+92,847
| +13% | +$2.92M |
|
1277
CALL
Elevance Health
ELV
$86.6B
| $20.7M | ﹤0.01% |
47,600
| – | – |
|
|
PPLI
1278
People Inc
PPLI
$3.02B
| $20.6M | ﹤0.01% |
547,471
+61,514
| +13% | +$2.24M |
|
|
PR
1279
Permian Resources
PR
$17.7B
| $20.6M | ﹤0.01% |
1,484,088
+440,815
| +42% | +$6.31M |
|
1280
CAVA Group
CAVA
$8.43B
| $20.5M | ﹤0.01% |
237,537
+83,500
| +54% | +$9.05M |
|
1281
Arm
ARM
$298B
| $20.5M | ﹤0.01% |
192,126
+32,876
| +21% | +$4.58M |
|
1282
Toast
TOST
$20.4B
| $20.5M | ﹤0.01% |
618,456
+407,518
| +193% | +$15.3M |
|
1283
Invesco Aerospace & Defense ETF
PPA
$8.68B
| $20.5M | ﹤0.01% |
175,903
+14,386
| +9% | +$1.69M |
|
1284
Agree Realty
ADC
$9.25B
| $20.5M | ﹤0.01% |
265,335
-6,674
| -2% | -$489K |
|
1285
PUT
Palo Alto Networks
PANW
$323B
| $20.5M | ﹤0.01% |
120,000
| – | – |
|
1286
Ingredion
INGR
$6.54B
| $20.5M | ﹤0.01% |
151,418
-11,173
| -7% | -$1.48M |
|
1287
JPMorgan Core Plus Bond ETF
JCPB
$14.2B
| $20.5M | ﹤0.01% |
434,826
+128,039
| +42% | +$5.95M |
|
1288
Fabrinet
FN
$20.3B
| $20.4M | ﹤0.01% |
103,518
-54,932
| -35% | -$12M |
|
1289
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
| $20.4M | ﹤0.01% |
400,679
+37,544
| +10% | +$1.91M |
|
1290
Rithm Capital
RITM
$5.79B
| $20.3M | ﹤0.01% |
1,776,105
+86,394
| +5% | +$999K |
|
1291
United Therapeutics
UTHR
$21.9B
| $20.3M | ﹤0.01% |
65,789
+32,867
| +100% | +$11.3M |
|
1292
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$608M
| $20.1M | ﹤0.01% |
461,206
+9,355
| +2% | +$430K |
|
1293
LCI Industries
LCII
$2.6B
| $20.1M | ﹤0.01% |
229,806
-31,203
| -12% | -$3.13M |
|
1294
PRA Group
PRAA
$762M
| $20.1M | ﹤0.01% |
973,695
-45,189
| -4% | -$958K |
|
1295
A.O. Smith
AOS
$8.51B
| $20.1M | ﹤0.01% |
306,824
-222,485
| -42% | -$15M |
|
1296
Adams Diversified Equity Fund
ADX
$3.31B
| $20M | ﹤0.01% |
1,054,872
+299,425
| +40% | +$6.01M |
|
1297
Textron
TXT
$15.3B
| $20M | ﹤0.01% |
277,088
+2,632
| +1% | +$197K |
|
1298
Xtrackers Russell US Multifactor ETF
DEUS
$307M
| $20M | ﹤0.01% |
373,004
-8,279
| -2% | -$451K |
|
1299
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$753M
| $20M | ﹤0.01% |
304,051
-6,072
| -2% | -$391K |
|
1300
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
| $20M | ﹤0.01% |
349,218
-16,747
| -5% | -$844K |
|
Similar funds
Royal Bank of Canada's Q1 2025 Portfolio in Review
As of Q1 2025, Royal Bank of Canada held 7,428 positions worth $479B, down 4.4% from $501B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q1 2025 filing shows 373 new, 3,020 increased, 3,038 reduced and 434 closed positions. Its largest new stake was Sandisk: 233,868 shares worth $11.1M. The largest sale was HCA Healthcare, an estimated $857M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q1 2025 buy was Sandisk: 233,868 shares worth $11.1M.
- Royal Bank of Canada added most to Canadian Natural Resources in Q1 2025, an estimated $1.33B increase.
- Royal Bank of Canada's biggest Q1 2025 reduction was HCA Healthcare, cutting an estimated $857M.
- Royal Bank of Canada fully exited Aspen Technology Inc in Q1 2025, selling an estimated $42.5M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $479B portfolio in Q1 2025.
- Royal Bank of Canada opened 373 new positions and closed 434 in Q1 2025.
- Royal Bank of Canada's portfolio value fell 4.4% quarter-over-quarter to $479B.
Based on Royal Bank of Canada's 13F filing for Q1 2025, filed 15 May 2025.